A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Upadacitinib in Subjects With Takayasu Arteritis (SELECT-Takayasu)
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Upadacitinib in Subjects With Takayasu Arteritis (SELECT-Takayasu)
The main objective of this study is to evaluate the efficacy of upadacitinib in combination with a corticosteroid taper regimen compared to placebo in combination with a corticosteroid taper regimen.
Inclusion Criteria:
Exclusion Criteria:
Ciudad Autonoma Buenos Aires, Buenos Aires 1180, Argentina
Salvador, Estado de Bahia 40150-150, Brazil
São Paulo, 05403-000, Brazil
Toon-shi, Ehime 791-0295, Japan
Kita-gun, Kagawa-ken 761-0793, Japan
Kawasaki-shi, Kanagawa 216-8511, Japan
Kawachinagano Shi, Osaka 586-8521, Japan
Sakai-shi, Osaka 590-0197, Japan
Suita-shi, Osaka 564-8565, Japan
Bunkyo-ku, Tokyo 113-8431, Japan
Bunkyo-ku, Tokyo 113-8519, Japan
Chuo-ku, Tokyo 104-8560, Japan
Shinjuku-ku, Tokyo 160-8582, Japan
Shinjuku-ku, Tokyo 162-8655, Japan
Shinjuku-ku, Tokyo 162-8666, Japan
Seoul, Seoul Teugbyeolsi 06591, South Korea
Istanbul, 34899, Turkey (Türkiye)
Meram Konya, 42080, Turkey (Türkiye)